Publication:
C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.

dc.contributor.authorAlonso-Titos, Juana
dc.contributor.authorPerea-Ortega, Lara
dc.contributor.authorSola, Eugenia
dc.contributor.authorTorres-Rueda, Alvaro
dc.contributor.authorLeón, Myriam
dc.contributor.authorToledo, Remedios
dc.contributor.authorDuarte, Ana D
dc.contributor.authorVazquez, Teresa
dc.contributor.authorMartinez-Esteban, Maria Dolores
dc.contributor.authorBailen, Alicia
dc.contributor.authorRuiz-Esteban, Pedro
dc.contributor.authorHernandez, Domingo
dc.date.accessioned2024-02-08T14:41:30Z
dc.date.available2024-02-08T14:41:30Z
dc.date.issued2018-06-08
dc.description.abstractMorbidity associated with monoclonal gammopathy of renal significance is high due to the severe renal lesions and the associated systemic alterations. Accordingly, early diagnosis is fundamental, as is stopping the clonal production of immunoglobulins using specific chemotherapy. A 75-year-old man with chronic renal disease of unknown origin since 2010 experienced rapid worsening of renal function over a period of 6 mos. Bone marrow biopsy showed monoclonal gammopathy of undetermined significance. Kidney biopsy showed the presence of C3 glomerulonephritis, with exclusive deposits of C3 visible on immunofluorescence and a membranoproliferative pattern on light microscopy. Skin biopsy showed endothelial deposition of complement. Given both the renal and cutaneous involvement the patient was considered to have monoclonal gammopathy of renal significance. We considered an underlying pathogenic mechanism for the renal alteration secondary to activation of the alternative complement pathway by the anomalous immunoglobulin. Despite treatment with plasmapheresis, bortezomib and steroids, advanced chronic kidney disease developed. The possible underlying cause of the monoclonal gammopathy of renal significance suggests that monoclonal gammopathy should be considered in adult patients with membranoproliferative glomerulonephritis.
dc.format.number1es_ES
dc.format.page129es_ES
dc.format.volume19es_ES
dc.identifier.doi10.1186/s12882-018-0927-0
dc.identifier.e-issn1471-2369es_ES
dc.identifier.journalBMC nephrologyes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/12565
dc.identifier.pubmedID29884135es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17606
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAlternative complement pathway
dc.subjectC3 glomerulonephritis
dc.subjectCase report
dc.subjectChronic kidney disease
dc.subjectMonoclonal gammopathy
dc.subject.meshAged
dc.subject.meshComplement C3
dc.subject.meshGlomerulonephritis
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshParaproteinemias
dc.titleC3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files